

| Dosage | Package | Price per Dose | Price | |
|---|---|---|---|---|
| 400mg | 180 pills | A$3.09 | A$695.16 A$556.13 Best Price Popular | |
| 400mg | 120 pills | A$3.22 | A$484.17 A$387.34 | |
| 400mg | 90 pills | A$3.44 | A$386.79 A$309.43 | |
| 400mg | 60 pills | A$3.70 | A$278.59 A$222.87 | |
| 400mg | 30 pills | A$4.11 | A$154.16 A$123.33 |
Disclaimer: This information is for general understanding and does not replace medical advice. Always follow your healthcare provider’s instructions and consult the official Pentasa patient information leaflet for Australia. If you have questions, speak with your pharmacist or doctor.
Pentasa is a brand name for mesalazine (also called mesalamine), a medicine used to help manage inflammatory bowel diseases. It contains small, specially coated particles designed to release in different parts of the gut. This targeted release aims to act where inflammation is occurring in the lining of the intestines.
In Australia, Pentasa may be prescribed by a doctor depending on local rules, and it is generally used to treat conditions such as ulcerative colitis and certain forms of Crohn’s disease that affect the small intestine and colon. The exact formulation is designed to deliver mesalazine to the gut while minimising systemic absorption.
Pentasa medication contains other ingredients in the capsule that help with stability and delivery. If you have allergies to any medicine ingredients, including medicines containing salicylates, tell your clinician before starting Pentasa. Read the patient information leaflets for complete ingredient lists and warnings.
This page provides general information to help you understand what Pentasa is and how it is used in gut inflammatory conditions. It is not a substitute for personalised medical advice. For questions about whether Pentasa is right for you, consult your doctor or pharmacist.
Remember that treatment plans may vary based on the exact diagnosis, disease location, and how your body responds. Always follow the prescribed plan and check with a healthcare professional if you have concerns about starting, stopping, or changing therapy.
Pentasa is used to reduce inflammation in the lining of the gut for adults and sometimes children under medical supervision. It is commonly prescribed for long-term maintenance of ulcerative colitis to help prevent flare-ups. The decision to use Pentasa depends on the individual’s condition and response to other therapies.
The medicine can be part of a broader treatment plan. It may be used during active flare-ups to help control symptoms and may be continued as a maintenance therapy to reduce the chance of relapse. Your clinician will determine the duration of treatment based on your disease course.
Pentasa is not an antibiotic or a pain reliever. It is an anti-inflammatory medication aimed at reducing inflammation in the gut. It is not a cure for inflammatory bowel disease, but it can help manage symptoms and improve quality of life for many people when used as directed.
Because disease activity and response to therapy vary, some patients may require adjustments to their treatment over time. It is important to maintain regular follow-up with your healthcare team, including any blood tests or imaging studies your doctor recommends.
In some situations, Pentasa may be used in combination with other medicines or therapies as part of a comprehensive treatment plan. Any combination therapy should be discussed with your treating clinician to ensure safety and effectiveness for your specific condition.
Mesalazine (the active ingredient in Pentasa) helps to reduce inflammation in the lining of the gut. It acts locally on the intestinal mucosa with the aim of lessening inflammatory processes that contribute to symptoms such as abdominal pain and diarrhoea. The exact mechanism is complex and involves modulation of inflammatory mediators and immune responses in the gut tissue.
Pentasa is formulated to release mesalazine at multiple points along the small intestine and colon. This targeted release helps the active drug reach areas where inflammation is present, while limiting systemic exposure. The design aims to limit widespread side effects and focus the therapeutic effect on the gut lining.
Because the medication acts locally in the gut, many people experience symptomatic benefits with relatively low systemic levels of the drug. This local action is a key feature of mesalazine formulations used in inflammatory bowel diseases.
Improvement in symptoms may take time and can vary between individuals. If you notice no improvement after several weeks, or if symptoms worsen, contact your healthcare provider for guidance. Do not change or stop your treatment without medical advice.
Your clinician may adjust other aspects of your treatment plan based on how you respond. It is important to report new or worsening symptoms, especially if they involve fever, severe abdominal pain, or blood in the stool, so that the plan can be reviewed promptly.
Take Pentasa exactly as prescribed by your doctor. The medicine is usually taken orally as capsules. Do not open, crush, chew, or break the capsules unless your clinician specifically tells you to do so. Swallow each capsule with a full glass of water.
Try to take Pentasa at about the same times each day to help you remember. Some regimens allow dosing with meals, while others do not; follow the instructions provided by your prescriber or the patient information leaflet. If you have trouble swallowing capsules, talk to your pharmacist or doctor about alternatives or approaches that are appropriate for you.
If you miss a dose and it is almost time for your next dose, skip the missed dose and resume your regular schedule. Do not double up to make up for a missed dose. If you are unsure what to do after a missed dose, contact your pharmacist or doctor for advice.
Store Pentasa at room temperature, away from moisture and heat, and out of reach of children. Do not use Pentasa after the expiry date printed on the packaging. Keep all medicines in their original packaging to protect them from light and moisture.
If you are pregnant, planning pregnancy, or breastfeeding, talk with your doctor about the risks and benefits of continuing Pentasa. Some women may use mesalazine during pregnancy under medical supervision, but this must be discussed with a clinician before continuing treatment. Do not start or stop any medicine during pregnancy without professional advice.
Avoid Pentasa if you have a known allergy to mesalazine or other salicylates, or to any of the other ingredients in the medicine. An allergic reaction could be serious, so seek medical help promptly if you notice symptoms such as swelling of the face or throat, severe rash, or trouble breathing.
People with significant kidney disease should discuss Pentasa with their doctor. The medicine is processed in the kidneys, and pre-existing kidney conditions may require monitoring or alternative treatments. Your clinician can determine whether Pentasa is appropriate for you based on your overall health and test results.
If you have severe dehydration, severe dehydration, or a history of kidney stones, tell your clinician before starting Pentasa. These conditions may affect how the medicine is used and whether monitoring is needed during therapy.
Because individual needs vary, do not assume you can use Pentasa simply because a friend or relative has used it. In some situations, dosage or the decision to use this medicine may differ. Always rely on your clinician’s guidance for your specific case.
If you are considering starting or continuing Pentasa during pregnancy or while breastfeeding, speak with your obstetrician or paediatrician. The benefits and risks must be weighed by a healthcare professional before continuing treatment in these settings.
Before starting Pentasa, inform your doctor about all other medicines you take, including herbal remedies and supplements. Some medicines can interact with mesalazine or affect how Pentasa works, so it is important to have a complete list when discussing treatment options.
If you experience persistent vomiting, severe abdominal pain, significant changes in bowel habits, persistent fever, or unusual bleeding, contact your clinician promptly. These may indicate a need for medical assessment or adjustments to therapy.
Long-term use of Mesalazine can be associated with rare adverse effects in some people, including changes in liver function or blood tests. Regular monitoring as advised by your clinician helps ensure safety during therapy.
If you have a history of severe allergic reactions or asthma, inform your doctor before starting Pentasa. While rare, serious reactions can occur with any medicine, and preventive monitoring helps manage risk.
Always seek urgent medical help if you think you are having a medical emergency, such as trouble breathing or a severe allergic reaction. Do not rely on self-diagnosis or delays in care.
Common side effects of Pentasa may include stomach upset, nausea, and diarrhoea. Some people also experience symptoms such as headache, abdominal cramps, or a feeling of fullness. These effects are typically mild and often improve with time or after dose adjustments by your clinician.
Less common side effects can include dizziness, skin rashes, or flushing. If you notice a new rash, swelling, or itching, contact your clinician to assess whether the treatment needs adjustment or discontinuation.
In rare cases, more serious side effects can occur, such as signs of an allergic reaction or problems with the liver or kidneys. If you notice dark urine, pale stools, persistent abdominal pain, or yellowing of the skin or eyes, seek medical attention promptly.
Because Pentasa is aimed at a local effect in the gut, systemic side effects are less common than with some other anti-inflammatory medicines, but they can still occur. Your doctor will explain which signs require urgent care and how to respond if you experience them.
If you have concerns about side effects, or if adverse symptoms affect your daily activities, contact your pharmacist or doctor. Do not stop the medicine without medical advice unless you are told to do so in an emergency situation.
Tell your doctor about all medicines you are taking, including over-the-counter products, vitamins, and herbal supplements. Some medicines can interact with Pentasa and may change how well either medicine works or increase the risk of side effects.
Avoid starting new prescriptions without discussing them with your clinician first. In particular, medicines that affect the kidneys or gut function, or other anti-inflammatory drugs, should be reviewed for potential interactions with Pentasa.
Your doctor may adjust the use of other medicines if you begin Pentasa, to ensure safety and optimise effectiveness. If you are planning any major changes to your therapy, discuss these with your healthcare provider first.
If you are undergoing surgery or have planned procedures, inform your surgeon or anaesthetist that you are taking Pentasa. Some medicines used around the time of surgery can interact with your bowel inflammation treatment and require adjustments.
Store this information and your medicine in a way that makes it easy to share with all of your healthcare providers. Clear communication helps prevent interactions and supports safe treatment continuation.
If you are pregnant or planning to become pregnant, discuss Pentasa with your doctor. Some patients may continue treatment under medical supervision if the benefits outweigh potential risks. Do not change therapy during pregnancy without professional advice.
Breastfeeding while taking Pentasa should be discussed with a clinician. It is important to weigh the potential benefits to the mother against any possible effects on the infant. Your doctor can help determine the safest approach for both mother and baby.
In general, many women with inflammatory bowel disease continue to receive necessary treatment during pregnancy under careful supervision. The decision is individual and based on disease activity and response to therapy.
If you experience any new symptoms during pregnancy or while breastfeeding, contact your healthcare provider promptly for advice. They may adjust the plan to maintain disease control while minimising risks to the baby.
Always rely on professional advice for pregnancy-related decisions about Pentasa. Do not alter the treatment plan without consulting your clinician first.
Response to treatment varies between individuals and depends on the condition being treated. Some people notice improvements in symptoms within weeks, while others may require longer to observe meaningful changes. Your clinician will monitor progress and may adjust therapy if needed.
If you miss a dose, take it as soon as you remember, unless your next dose is due soon. If it is nearly time for your next dose, skip the missed dose and resume your regular schedule. Do not double up to make up for a missed dose. If you are unsure, contact your pharmacist or doctor for guidance.
Tell your doctor about all medicines and supplements you take, as some may interact with Pentasa or affect how well it works. Do not start new medicines without professional advice. Your clinician can assess potential interactions and adjust your plan if needed.
Seek medical advice if you notice persistent or worsening symptoms, severe abdominal pain, fever, unusual bleeding, or signs of an allergic reaction. Also contact your clinician if you have significant changes in kidney function tests or liver enzymes as advised by your healthcare team.
Unless advised by your clinician, do not stop Pentasa suddenly, and do not alter the dose on your own. Your doctor will determine when it is appropriate to reduce or stop therapy based on your disease activity and response to treatment.
The duration of treatment varies by condition and response. Some people use Pentasa for maintenance to reduce flare-ups over months or years, while others may require shorter courses during active disease. Your clinician will plan follow-up and monitoring accordingly.
While Pentasa can often be taken with or without food, follow the exact instructions given by your doctor. Eating patterns and the timing of doses can influence how well you tolerate the medicine for some people. If you have concerns about meals, ask your pharmacist or clinician for guidance.
Store Pentasa at room temperature in a dry place, away from heat and moisture. Keep it out of reach of children. Do not use it after the expiry date printed on the packaging. Proper storage helps preserve potency and reduces the risk of accidental exposure.
Moderate or occasional alcohol use is generally considered unlikely to interact with Pentasa in a harmful way for many people. However, alcohol can irritate the gut and may worsen certain symptoms. Discuss your alcohol use with your clinician if you have concerns.
If you develop signs of a serious reaction such as swelling, skin rash with itching, trouble breathing, or severe abdominal pain, seek urgent medical help. Do not delay care while waiting for a routine appointment.
Tell your healthcare team that you are taking Pentasa before any planned surgery or medical procedures. They can determine whether any adjustments are needed for safe perioperative management.
The information provided here reflects general guidance for Pentasa use in Australia. For the most accurate and up-to-date details, consult the official patient information leaflet supplied with the medication and discuss any questions with your pharmacist or doctor. Your treatment plan should be guided by your clinician, who can tailor advice to your specific health needs.
14–21 days. Free from A$279.23 .
5–9 days. A$41.88
−10% when paying with cryptocurrency.
−10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.
